CTOs on the Move

Rural Wisconsin Health Cooperative

www.rwhc.com

 
Rural Wisconsin Health Cooperative is a Sauk City, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.rwhc.com
  • 880 Independence Ln
    Sauk City, WI USA 53583
  • Phone: 608.643.2343

Executives

Name Title Contact Details

Similar Companies

FocusOne

FocusOne is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aerie Pharmaceuticals

Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care. Aerie Pharmaceuticals discovers, develops, and commercializes first-in-class therapies for the treatment of patients with glaucoma, retinal diseases and other diseases of the eye. See the future of eye care with Aerie.

Innovative Labs

Innovative Labs (IL) is a leading developer, formulator, and provider of single serve and multi-dose ingestible health and wellness products for leading brands and direct sales companies.

Clarendale of Bellevue Place

Clarendale at Bellevue Place is a senior living community located in Nashville, TN that offers independent living, assisted living, and memory care services.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.